| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |